Rethinking Dengue Surveillance in Bangladesh
Published in Social Sciences, Microbiology, and Public Health
Explore the Research
Evaluating surveillance systems to understand dengue burden in Bangladesh: a narrative review
Dengue has long been a familiar public health threat in Bangladesh, but the scale and severity of recent outbreaks have been unprecedented. When Bangladesh experienced its deadliest dengue outbreak in 2023, with over 320,000 reported cases and more than 1,700 deaths, it became clear that traditional ways of understanding and responding to dengue transmission were no longer sufficient. This moment prompted us to step back and ask a fundamental question: how well do existing dengue surveillance systems in Bangladesh actually capture the evolving burden of disease—and where are the gaps?
This narrative review emerged from that question. Rather than focusing on a single dataset or method, we set out to synthesize what is already known about dengue surveillance in Bangladesh across multiple approaches, including passive and active surveillance, community-based systems, early warning tools, forecasting, and predictive modeling. Our goal was not only to catalog these systems, but also to understand how they function together—or, in many cases, fail to do so.
As we reviewed the literature, one of the most striking findings was the fragmentation of dengue surveillance efforts. Hospital-based passive surveillance provides nationwide coverage and remains the backbone of reporting, yet it is vulnerable to underreporting and delays. Community-based and active surveillance approaches often offer earlier signals of transmission but are rarely integrated into national systems. Forecasting and predictive models show promise for anticipatory outbreak detection, but they depend heavily on the quality and consistency of routine surveillance data and are seldom linked to real-time public health decision-making.
Another unexpected observation was the lack of standardized definitions. Across the studies we reviewed, very few clearly defined what constitutes a dengue outbreak, and only one explicitly referenced a dengue case definition. This absence complicates comparisons across studies and surveillance systems and underscores the need for greater standardization to improve interpretability and response.
Conducting this review also highlighted the importance of thinking about surveillance not as a single tool, but as a system—one that depends on governance, data integration, service delivery, and coordination across sectors. Drawing on the WHO Health System Building Blocks framework helped us situate surveillance within a broader health system context and identify where integration could be strengthened.
We hope this review contributes to ongoing conversations about how dengue surveillance can evolve in Bangladesh and similar high-burden, resource-constrained settings. More cohesive, mixed surveillance approaches—combining routine reporting, community-level data, and predictive analytics—have the potential to support earlier detection, better preparedness, and more timely response. Ultimately, strengthening surveillance is not just about better data; it is about enabling public health action that can save lives.
Follow the Topic
-
Discover Public Health
This is an open access journal publishing research from all fields relevant to public health.
Related Collections
With Collections, you can get published faster and increase your visibility.
Public Health Strategies for the Management and Prevention of Tobacco Use and Emerging Tobacco Products
Tobacco use is considered as one of the hidden epidemics of the 21st century. Despite many efforts at policy level, tobacco use still remain one of the key factors for high morbidity and mortality worldwide. Globally around eight million people die due to tobacco consumption while daily people are diagnosed with lung cancer, COPD, cardiovascular diseases etc., with main factor being the tobacco consumption. Tobacco prevalence range between and within regions and countries as well as between male and female gender. Tobacco uses usually starts at adolescent and continue in the later life. At global level several initiatives have been undertaken with the WHO-FCTC being one of the most important. Additionally, at national levels countries have undertaken several initiatives but with not very successful results. On the other hand, tobacco industry is putting priority in the new products such as electronic cigarettes, heated tobacco etc. These products are not considered in many regions and countries as the normal tobacco products with their taxation, availability and use being different. To some extent, healthcare systems are not performing well in the management of the tobacco use which is considered a chronic condition. Availability of new medicaments and approaches and techniques is still a problem in many settings worldwide. Combination of tobacco use and other substances is also a critical issue.
This Collection aims to discuss key strategies for management of tobacco use and the new products at local, national, regional and global level as well as to propose key measures for healthcare personnel and policymakers in order to manage key challenges. Authors from different settings and different backgrounds are invited to submit their works to this Collection. Reviews and systematic analyses and meta- analyses, original articles, policy papers and case-studies are more than welcome to be submitted.
Research areas may include but are not limited to the following:
- Tobacco consumptions
- New tobacco products
- Prevention and management of tobacco use
- Substance use
- Technology and public health
- Prevention and health promotion
Keywords: tobacco, heated tobacco, public health, health policy, prevention and health promotion
This Collection supports and amplifies research related to SDG 3.
Publishing Model: Open Access
Deadline: Apr 30, 2026
Antimicrobial Resistance: The New Challenge to Global Health in a Post-Pandemic World
Antimicrobial resistance (AMR) is a seriously ongoing threat to global health, occurring when bacteria, fungi, viruses, and parasites evolve to resist the drugs designed to kill or block them. The COVID-19 pandemic has both directly and indirectly exacerbated the problem of AMR, as the overuse of antibiotics has accelerated the development of resistance in many pathogens. COVID-19 may have subsided, but AMR continues to pose a significant risk to the effectiveness of global healthcare systems, threatening to reverse decades of progress in combating infectious diseases. The interplay between population health and AMR has become increasingly critical as healthcare practices have shifted in response to the pandemic. Understanding this relationship is essential for developing effective strategies to mitigate the impact of AMR on population health in a post-COVID context.
The motivation for launching this Collection arises from the urgent need to address the rising tide of AMR as healthcare systems grapple with the long-term effects of the pandemic. Increased antibiotic use during COVID-19 treatment, changes in healthcare access, and disruptions in public health interventions have all contributed to an environment where AMR can thrive. Moreover, the pandemic has highlighted the importance of a multidisciplinary approach to tackling AMR, involving epidemiology, policymaking, and community health initiatives. This Collection aims to provide a platform for researchers and practitioners to share insights and findings that can inform future strategies to combat AMR while considering the broader implications for population health.
This Collection aims to highlight the multifaceted nature of AMR in a post-pandemic environment. We solicit articles that investigate the particular issues provided by the pandemic in terms of AMR development and containment, examine the impact of AMR on many sectors of healthcare, and propose novel strategies to minimize resistance propagation. Submissions may include original research, policy assessments, program evaluations, and comments on the following major areas:
• Epidemiology and trends of AMR post-pandemic
• Impact of COVID-19 on antibiotic usage
• Surveillance strategies for AMR
• AMR and stewardship
• Prevention and control measures to limit AMR spread
• Policies and programs to promote antibiotic stewardship
• Economic and social implications of AMR
• Global collaboration and initiatives to tackle AMR
By addressing these critical issues, this Collection aims to provide a comprehensive understanding of the emerging challenges in antimicrobial resistance in a post-pandemic world and to promote effective strategies to preserve the power of our current antimicrobials.
Keywords: antimicrobial resistance; COVID-19; antibiotics; global health; infectious diseases; public health; policy; prevention
This Collection supports and amplifies research related to SDG 3.
Publishing Model: Open Access
Deadline: Jun 30, 2026
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in